CVS Group (CVSG) H1 analyst presentation given 25.3.21
PIWORLD audio investor podcasts - A podcast by piworld

Categories:
This video can be seen at: https://www.piworld.co.uk/2021/03/26/cvs-group-cvsg-h1-analyst-presentation-given-25-3-21/ Richard Fairman, CEO, Robin Alfonso, CFO and Ben Jacklin, COO present the CVSG interim results to analysts. Richard Fairman, CEO 00:18 Introduction 01:09 H1 highlights 01:55 UK Pet Market 03:45 Integrated model 07:15 Trading with CV19 10:15 Acquisitions Robin Alfonso, CFO 10:55 Financial review Ben Jacklin, COO 16:30 Operational update Richard Fairman, CEO 22:15 Outlook Q&A 24:16 CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals. The Laboratories segment provides diagnostic services to its veterinary practices and third-parties. Its laboratories provide Biochemistry, haematology, histology, serology and advanced allergy testing. The Pet Crematoria segment offers pet cremation services to its veterinary practices, third-party practices and directly to pet owners. The Animed Direct segment sells prescription and non-prescription drugs, pet food and other animal related products through its Website. It operates approximately 360 veterinary practices, four diagnostic laboratories, seven pet crematoria and an online dispensary.